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270Objectives: Cardiovascular complications are a major cause of morbidity and mortality among renal transplant
recipients. This study assessed perioperative risk factors for mortality and long-term outcomes in renal trans-
plant recipients who underwent cardiac surgery.
Methods: From 1999 to 2010, 92 renal transplant recipients with a functioning allograft underwent cardiac sur-
gery at our institution. Cardiac procedures included coronary artery bypass grafting (43 patients, 46%), isolated
valve surgery (17 patients, 18%), combined coronary artery bypass grafting and valve surgery (18 patients,
19%), and aortic procedures (7 patients, 7%).
Results: Transient renal failure requiring dialysis occurred in 20 of 92 patients (21%), with 3 not recovering
renal function and returning to a permanent dialysis regimen while in the hospital. After cardiac surgery
30-day, 1-year, 5-year, and 8-year survival rates were 89%, 72%, 47%, and 30%, respectively. Freedom
from dialysis was 90% after 1 year, 66% after 5 years, and 49% after 8 years. Risk factors for 30-day mortality
were age> 65 years, left ventricle ejection fraction< 35%, and a combined cardiac procedure. Pulmonary
hypertension and diabetes were risk factors for death from a cardiac cause after discharge. Diabetes, dyslipide-
mia, preoperative use of an intra-aortic balloon pump, postoperative creatinine>2 mg/dL, and transient renal
failure requiring dialysis were associated with a permanent dialysis requirement after cardiac surgery.
Conclusions: Cardiac surgery in patients receiving renal transplant who have functioning allograft has accept-
able outcomes. If combined procedures are required, patients should be carefully considered. Transient postop-
erative renal impairment, even if resolved at discharge, increases the risk for allograft failure during long-term
follow-up. (J Thorac Cardiovasc Surg 2014;147:270-5)There are an increasing number of patients with prior kid-
ney transplantation who require cardiac surgery. Risk fac-
tors leading to end-stage renal disease, such as diabetes
and hypertension, predispose kidney transplant recipients
to cardiovascular complications. In addition, the immuno-
suppressant regimen required after transplant is associated
with deterioration of native coronary disease.1 Survival of
renal transplant recipients who undergo cardiac surgery
has improved, with perioperative mortality ranging from
1.4% to 9% in recent reports, as a result of careful patient
selection, adequate immunosuppressive therapy, and better
postoperative management.2-8 Most of those studies
included both transplant recipients with a functional renal
allograft who did not require permanent dialysis and
transplant recipients with a failing renal allograft whoe Department of Cardiothoracic Surgery,a and Thomas E. Starzl Transplanta-
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However, renal transplant recipients who undergo cardiac
surgery and require permanent dialysis have different
characteristics and outcomes than recipients who do not
require dialysis.9 There are few reports analyzing short-
and long-term outcomes of patients with a functioning renal
allograft who undergo cardiac surgery.2,4 Moreover,
a majority of the procedures described are coronary artery
bypass grafting (CABG) or isolated valve surgeries; thus,
the outcomes following other cardiac procedures, such
as combined CABG and valve surgeries or aortic
reconstructive procedures, remain unclear. The purpose of
this study was to assess perioperative risk factors for
mortality and long-term outcomes in renal transplant recip-
ients with a functioning allograft who underwent cardiac
surgery.
PATIENTS AND METHODS
Patients
Data from our prospectively collected surgical database was retrospec-
tively analyzed with the need for patient consent waived by the University
of Pittsburgh Institutional Review Board. Mortality was confirmed using
patient records and the Social Security Number Death Index. We identified
92 consecutive patients with a prior renal transplant and a functioning renal
allograft who underwent cardiac surgery at the University of Pittsburgh
Medical Center between July 1999 and April 2010. Five patients were
also liver transplant recipients with functioning liver and kidney allograftsery c January 2014
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
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Dat the time of the cardiac procedure. The mean follow-up was 4.2  3.1
years for discharged patients.
Surgery
All patients received a stress dose of steroids before anesthesia induc-
tion. Standard surgical techniques were used.
Cardiopulmonarybypass (CPB)flowwas routinelymaintained toprovide
a cardiac index of 2.2 to 2.4 L/minute/m2 and a mean arterial pressure>60
mm Hg, using a roller pump and vasoconstrictors (ie, phenilephrine and
norepinephrine), if required, during bypass. Hematocrit was maintained
>21%, transfusing packed red blood cells per the surgeon’s preference.
During the early operative period, per operative intensive care unit pro-
tocol, mean arterial pressure was maintained in a range from 60 to 70 mm
Hg and central venous pressure was maintained from 12 to 15 mm Hg.
At first, colloids (albumin and hetastarch) were used to maintain ade-
quate intravascular volume. Thereafter, mild to moderate vasoconstrictor
doses were used selectively, as needed, avoiding their use in patients
with severe preoperative renal dysfunction.
A target urine output of 0.5 to 1 mL/kg/hour was intended during CPB.
Diuretics (ie, furosemide) were used if persistent oliguria was noted.
When CABG was performed, the use of the off-pump versus on-pump
technique was based on the surgeon’s preference. When cardioplegia was
required, intermittent doses of cold bloodwere administered in the standard
fashion.
Postoperative Care
Standard perioperative management was used. Inotropes and vasocon-
strictors were used intraoperatively and postoperatively, as needed, to
stabilize hemodynamics. Special care was taken to maintain adequate renal
perfusion pressure and to avoid all nephrotoxic drugs. Serum creatinine
levels were closely monitored to assess renal function.
Immunosuppressive Therapy
All patients received their routine immunosuppressivemedications until
the evening before the cardiac surgery. Postoperatively, each patient’s im-
munosuppression regimen was adjusted and closely monitored based on
serum drug levels.
Statistical Analysis
Continuous variables are shown as means standard deviation. Actuar-
ial survival estimates were calculated using Kaplan–Meier life table anal-
ysis. Cox proportional-hazards regression was used to determine risk
factors for 30-day survival, cardiac cause of death after discharge, and per-
manent renal failure requiring regular dialysis. Pre-, peri-, and postopera-
tive variables with P<.2 from univariate analyses were retained for the
multivariate regression tests. Statistical analysis was performed using
SPSS version 18 (IBM Corp, Armonk, NY) software.RESULTS
Patient Demographics
Preoperative characteristics of the 92 renal transplant re-
cipients with a functioning allograft who underwent cardiac
surgery are detailed in Table 1. All patients were following
an immunosuppressive regimen. These included 76 patientsThe Journal of Thoracic and Careceiving tacrolimus (82%), 50 patients receiving predni-
sone (54%), 33 patients receiving mycophenolate mofetil
(36%), 13 patients receiving cyclosporine (14%), 13 pa-
tients receiving azathioprine (14%), and 2 receiving siroli-
mus (2%). Fifty-seven patients (62%) were receiving
prophylactic antibiotic therapy with oral sulfamethoxa-
zole/trimethoprim at the time of their cardiac surgery.
Operative and Postoperative Characteristics
The interventions performed are outlined in Table 2. In
this high risk cohort, 15 patients (16%) were deemed to re-
quire urgent or emergent surgery. Mechanical support was
required postcardiotomy in 7 patients (8%), due to failure
to wean from CPB. An intra-aortic balloon pump was
implemented immediately postoperatively in 6 patients
(6%), with 2 of these patients also requiring extracorporeal
membrane oxygenation support with cannulation on the
contralateral side from the renal allograft anastomosis. In-
trahospital postoperative patient and allograft outcomes
are presented in Table 3.
We subdivided our population into 5 groups (ie, CABG
only, valve only, combined, aortic, and other). Mean CPB
time and clamp time, respectively, were 107 minutes and
57 minutes for the CABG only group, 117 minutes and 90
minutes for the valve only group; 133 minutes and 97 min-
utes for the other procedures group, 173 minutes and 128
minutes for the combined group, and 200 minutes and 159
minutes for the aortic group (P¼ .01 and .002, respectively).
Glomerular filtration rates were not available after sur-
gery. Mean intrahospital peak creatinine was 3.3  1.9
mg/dL and mean discharge creatinine was 2.2  1.3
mg/dL in patients not back to permanent dialysis on dis-
charge. Compared with the mean preoperative creatinine
(2.1 mg/dL), there was a mean creatinine elevation of 1.2
mg/dL while in the hospital with near preoperative levels
of creatinine at the time of discharge (mean elevation of
0.1 mg/dL compared with preoperative creatinine). Tran-
sient renal failure requiring dialysis occurred in 20 patients
(22%). Three of these patients did not recover renal func-
tion and required permanent dialysis.
PATIENT SURVIVAL
For the entire cohort, overall unadjusted survival was
88% 30 days after cardiac surgery, 72% after 1 year,
47% after 5 years, and 30% after 8 years (Figure 1, A).
Of the 11 patients who had a 30-daymortality, 3 patients un-
derwent isolated CABG and their causes of death included
cardiogenic shock, sepsis, and massive gastrointestinal
bleeding. One patient died after mitral valve replacement
surgery due to progressive heart failure. Four patients who
underwent combined CABG and valve surgery died in the
hospital from multiorgan failure (2 patients), sepsis, or car-
diogenic shock. Two patients who underwent an aortic pro-
cedure did not survive for 30 days after surgery. Bothrdiovascular Surgery c Volume 147, Number 1 271
TABLE 1. Patient demographics (N ¼ 92)
Characteristic n (%)
Mean age (y) 57  11
Female 34 (36)
Comorbidities
Diabetes 57 (61)
Insulin-dependent 49 (53)
Hypertension 81 (88)
Hyperlipidemia 42 (45)
Smoking history 30 (32)
CVA 8 (8)
PVD 55 (59)
COPD 12 (13)
Mean preopoerative creatinine (mg/dL) 2.1  1.2
Mean preoperative GFR (mL/min) 40  21
Previous PCI 15 (16)
Mean preoperative LVEF (%) 47  11
>45 59 (64)
<45 –>35 21 (23)
<35 12 (13)
Emergency operation 15 (16)
Recent AMI (<90 d) 19 (20)
Pulmonary hypertension (systolic pressure>60 mm Hg) 22 (24)
Preoperative IABP 3 (3)
Active endocarditis 4 (4)
Mean duration of renal allograft (y) 8.2  6.2
Initial cause of renal transplantation
Diabetes 29 (31)
Hypertension 12 (13)
Nephritis 31 (34)
Obstructive 5 (5)
Polycystic kidney disease 7 (7)
FK toxicity 2 (2)
Other cause 6 (6)
CVA, Cerebrovascular accident; PVD, peripheral vascular disease; COPD, chronic
obstructive pulmonary disease; GFR, glomerular filtration rate; PCI, percutaneous
cardiac intervention; LVEF, left ventricular ejection fraction; AMI, acute myocardial
infarction; IABP, intra-aortic balloon pump; FK, FK506 (tacrolimus).
TABLE 2. Operative data (N ¼ 92)
Operative characteristic n (%)
Type of surgery
Isolated CABG 43 (46)
Off-pump 22 (23)
Isolated valve 17 (18)
AVR 7 (7)
MVR/repair 7 (7)
TVR 2 (2)
AVR þ MVR 1 (1)
Combined CABG þ valve 18 (19)
CABG þ AVR 9 (10)
CABG þ MVR/repair 6 (6)
CABG þ AVR þ MVR 2 (2)
CABG þ AVR þ MVR þ TVR 1 (1)
Aortic reconstructive procedure 7 (7)
Ascending aortic repair/dissection 4 (4)
Ascending aortic repair/nondissection 3 (3)
Other 7 (7)
Septal myectomy þ MVR 3 (3)
CABG þ maze procedure 2 (2)
LV reconstruction 1 (1)
Removal of right atrial mass 1 (1)
Mean grafts used/CABG 2.6  1.3
Arterial grafts 57
Bioprosthetic valve 8 (8)
Mechanical valve 24 (26)
Mean operative time (min) 365  330
Mean cardiopulmonary bypass time (min) 152  140
Mean aortic cross clamp time (min) 110  105
IABP 6 (6)
ECMO 3 (3)
CABG, Coronary artery bypass grafting; AVR, aortic valve replacement;MVR, mitral
valve replacement; TVR, tricuspid valve repair; LV, left ventricle; IABP, intra-aortic
balloon pump; ECMO, extracorporeal membrane oxygenation.
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Dpresented to the hospital with type A aortic dissection,
which was corrected surgically but progressed into cardio-
genic shock. The other mortality within 30 days of cardiac
surgery occurred after a combined CABG and maze proce-
dure and was due to progressive heart failure.
Discharge was possible in 81 patients. At a mean follow-
up of 4.2  3.1 years, late mortality occurred in 46 of 81
patients (56%). Fifteen patients had a cardiovascular cause
of death after discharge, including acute myocardial infarc-
tion (7 patients), heart failure (4 patients), cerebrovascular
accident (3 patients), and endocarditis (1 patient). Noncar-
diac causes of death after discharge included progressive
renal failure (6 patients), sepsis (5 patients), head trauma
(2 patients), and drug hepatotoxicity (1 patient). The other
17 patients died from unknown causes.
Among the 46 patients who died during follow-up, 13 of
46 (28%) died under a dialysis regimen and 33 patients
(72%) died with a functioning allograft.272 The Journal of Thoracic and Cardiovascular SurgAllograft Survival
Three patients (3%) with a functional allograft preoper-
atively were discharged with a permanent need for dialysis.
One-year freedom from dialysis was 90%. Mean creatinine
was 2.8 2.0 mg/dL 1 year after cardiac surgery. Five-year
actuarial freedom from dialysis occurred in 66% and 8-year
freedom from dialysis in 49% (Figure 1, B). At a mean
follow-up of 4.2 3.1 years, 3 of the 23 patients who even-
tually returned to permanent dialysis due to allograft failure
received a second renal transplant. All of them were alive at
the time of this report.Risk Factor Assessment
Multivariate analysis of risk factors for 30-day mortality,
death from a cardiac cause after discharge, and renal allo-
graft failure requiring permanent dialysis after cardiac sur-
gery are presented in Table 4. Risk factors for 30-day
mortality after cardiac surgery were age> 65 years, left
ventricle ejection fraction< 35%, and having undergone
a combined CABG þ valve procedure. Pulmonaryery c January 2014
TABLE 3. Postoperative patient and allograft outcomes (N ¼ 92)
Early postoperative characteristic n (%)
Extubation within 24 h 59 (64)
Prolonged MV>3 d 20 (21)
Reintubation 9 (10)
Tracheostomy 8 (8)
Infection
Superficial wound 1 (1)
Leg wound 2 (2)
Pneumonia 7 (7)
Sepsis 6 (6)
UTI 2 (2)
Atrial fibrilation 27 (29)
CVA 6 (6)
Mean intrahospital peak creatinine (mg/dL) 3.3  1.9
Mean discharge creatinine (mg/dL) 2.2  1.3
Need for intrahospital dialysis 20 (22)
Reoperation for bleeding 3 (3)
AMI 2 (2)
Ischemic bowel 4 (4)
30-d mortality 11/92 (12)
30-d mortality by procedure
CABG 3/43 (6)
Valve 1/17 (5)
CABG þ valve 4/18 (22)
Aortic procedure 2/7 (28)
Other 1/7 (14)
MV, Mechanical ventilation; UTI, urinary tract infection; CVA, cerebrovascular acci-
dent; AMI, acute myocardial infarction; CABG, coronary artery bypass grafting.
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mm Hg) and diabetes as the primary cause for kidney trans-
plantation were risk factors for death from a cardiac cause
after discharge. Diabetes, dyslipidemia, preoperative use
of an intra-aortic balloon pump, postoperative creatinine
>2 mg/dL, and temporary need of dialysis perioperatively
were associated with an increased risk for permanent allo-
graft failure requiring dialysis after cardiac surgery.DISCUSSION
With continued improvements in the medical manage-
ment and long-term survival of renal transplant recipients,
the need for eventual cardiac surgery in these high risk pa-
tients is increasing in frequency. It is clear that a cardiovas-
cular impairment requiring invasive intervention shortens
life expectancy of renal allograft recipients. According to
the US Renal Data System 2010 annual data report,10 the
5-year survival of kidney recipients ranges from 80% to
89%. Nevertheless, the reported short- and long-term sur-
vival rates after cardiac surgery in renal transplant recipi-
ents are acceptable. Cardiovascular events are responsible
for a majority of deaths in renal transplant recipients,11,12
and renal transplant recipients would experience significant
morbidity and mortality if cardiac interventions were not
performed.The Journal of Thoracic and CaIn this study, we present an analysis of outcomes of pa-
tients with functioning renal allografts following a wide
range of different cardiac surgery procedures. We found
that surgery in these patients have acceptable outcomes,
but that transient postoperative renal impairment, even if re-
solved at discharge, increases the risk for allograft failure
during long-term follow-up. Because patients who had
a combined CAGB and valve surgery are at increased risk
for 30-day mortality, the renal transplant recipient’s selec-
tion for surgery should be carefully considered if combined
cardiac procedures are required.
The 30-day mortality of our cohort (12%) was slightly
higher than the range previously reported for renal trans-
plant recipients who undergo cardiac surgery. For instance,
Herzog and colleagues7 reported a 30-day mortality of 5%
to 9.4% for patients who underwent CABG after a renal
transplant. In a recent single-center study, Ono and col-
leagues2 presented their experience with 46 kidney recipi-
ents who underwent cardiac surgery, reporting a 30-day
mortality of 4.3%, with isolated CABG surgery comprising
76% of the procedures and isolated valve surgeries com-
prising 20% of the procedures in the kidney recipients.
John and colleagues3 reported a 1.4% mortality within 30
days after cardiac surgery, with isolated CABG comprising
93% of the performed interventions in their series of 70
patients. Our study differed from these studies; only 46%
of patients underwent isolated CABG and 19% underwent
isolated valve procedures. Mortality occurred within 30
days of surgery in only 6% of patients who underwent iso-
lated CABG, as presented in a previous study,13 which is
consistent with previous reports.7 Furthermore, 18 cases
(19%) in our series were combined CABG and valve proce-
dures, which was identified as a risk factor for 30-day mor-
tality in our multivariable analysis. This is consistent with
a previous study by Sharma and colleagues8 that suggested
combined cardiac procedures may influence early mortality.
In Sharma’s series, this finding did not reach statistical sig-
nificance, possibly due to the fact that the study compared
combined CABG and valve surgery with isolated valve sur-
gery, and isolated CABG was not included in the analysis.
We also included 7 cases (7%) of aortic procedures in our
series, and these patients had a 30-day mortality of 28%
(2 of 7 patients). Although aortic reconstructive procedures
had high in-hospital mortality, this intervention was not
identified as a multivariable risk factor for early death,
likely limited by the small sample size of only 7 patients.
Long-term survival in renal transplant recipients who
undergo valve replacement have noted a 52.8% overall
survival in 5 years.8 In our cohort, survival was similar,
with 47% surviving 5 years after cardiac surgery. Ono
and colleagues2 reported a higher survival after the same
follow-up period, with 67.9% of the patients alive. We
believe that our results reflect the nature of our study popu-
lation, with a higher number of cases of combined CABGrdiovascular Surgery c Volume 147, Number 1 273
FIGURE 1. Survival and freedom fromdialysis after cardiac surgery.A,Kaplan-Meier 8-year actuarial survival of renal transplant recipientswho underwent
cardiac surgery. B, Kaplan-Meier 8-year actuarial freedom from dialysis of renal transplant recipients who underwent cardiac surgery. Cum, Cumulative.
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Dand valve surgery or aortic surgery carrying an increased
morbi-mortality.
In our series, 22% of patients required dialysis perioper-
atively due to transient renal failure. In other studies of car-
diac surgery in renal transplant recipients with functioning
allograft,2,4 a lower rate of postoperative in-hospital dialysis
was reported. Because the mean preoperative creatinine
levels in our patients were similar to levels reported in those
studies, we believe that the kidney may be significantly274 The Journal of Thoracic and Cardiovascular Surgaffected during the surgical procedure. The mean CPB
and aortic cross clamp times were remarkably higher in
our overall 92 cases when compared with other reports,
and particularly in the 20 patients in whom intrahospital
postoperative dialysis was required, with a mean cardiopul-
monary bypass duration of 170 63 minutes and mean aor-
tic cross clamp time of 126  58 minutes. However, only
a small number of patients did not recover renal function
and most were discharged without requiring a permanentery c January 2014
TABLE 4. Multivariable Cox proportional hazards analysis for risk
factors of 30-day mortality, cardiac cause of death, and permanent
dialysis following complex cardiac surgery in patients with
functioning renal allografts
Dependent
variables Risk factor HR (95% CI)
P
value
30-d mortality
Age>65 y 7.22 (1.720-30.314) .007
LVEF<35% 6.77 (1.60-28.63) .009
CABG þ Valve 9.760 (1.798-52.976) .008
Death from a cardiac
cause after
discharge
PHTN 3.26 (1.086-9.790) .035
Diabetes as cause
of kidney Tx
3.865 (1.109-13.46) .034
Permanent dialysis
required after
discharge
Diabetes 4.731 (1.521-14.718) .007
Dyslipidemia 2.581 (1.077-6.185) .033
Preoperative IABP 12.01 (1.22-117.82) .033
Postoperative
creatinine
>2 mg/dL
8.082 (1.553-42.05) .013
Need for temporary
dialysis
4.186 (1.298-13.49) .016
HR, Hazard ratio; CI, confidence interval; LVEF, left ventricular ejection fraction;
CABG, coronary artery bypass grafting; PHTN, pulmonary hypertension; Tx, trans-
plant; IABP, intra-aortic balloon pump.
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level was similar to the preoperative level (2.2 mg/dL vs
2.1 mg/dL, respectively).
Freedom from dialysis 5 and 8 years after cardiac surgery
in our cohort was consistent to other reports.2 However, in
our analysis, most risk factors associated with long-term
permanent allograft failure were related to postoperative re-
nal function parameters (need for temporary dialysis and
postoperative creatinine>2 mg/dL) and primary preopera-
tive renal allograft comorbidities (diabetes and dyslipide-
mia). These findings suggest that even with normalization
of the creatinine values and allograft function at discharge
in almost all cases, the transient renal impairment caused
by the surgery may influence long-term allograft survival.
The limitations of the study are its retrospective nature
and the relatively small number of patients included in our
analysis. Nonetheless, to our knowledge, this series is cur-
rently the largest single-institution experiencewith complexThe Journal of Thoracic and Cacardiac surgery in patients with a functioning renal allograft.
As such, the results from this reportmay provide guidance as
to outcome trends, although a larger and perhaps multi-
institutional study to corroborate to our findings is needed.
CONCLUSIONS
Cardiac surgery in renal transplant recipients with a func-
tioning allograft has acceptable outcomes. If combined car-
diac procedures are required, the indications for surgical
intervention should be carefully considered in this patient
population. Patients with transient postoperative renal im-
pairment, even if resolved at discharge, should be closely
monitored during long-term follow-up for late allograft
failure.
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